Dr Kimberly Stegmaier

Kimberly Stegmaier, MD, Professor of Pediatrics at Harvard Medical School, and the Ted Williams Investigator at Dana-Farber Cancer Institute (DFCI), has pioneered the application of genomics to drug and protein target discovery for pediatric malignancies.  

Dr. Stegmaier is the Vice Chair for Pediatric Oncology Research, Co-director of the Pediatric Hematologic Malignancy Program, and a pediatric oncologist at DFCI and Boston Children’s Hospital (BCH). She is an Institute Member of the Broad Institute, a Board Member of the American Association for Cancer Research (AACR), and the outgoing Chair of St. Jude Children’s Research Hospital’s Scientific Advisory Board.  

Dr. Stegmaier received the Joanne Levy, MD, Memorial Award for Outstanding Achievement (American Society of Hematology), a Stand Up to Cancer Innovative Research Grant, an E. Mead Johnson Award for Research in Pediatrics, the NCI Outstanding Investigator Award, and a St. Baldrick’s Foundation Robert J. Arceci Innovation Award. She was elected to the American Society of Clinical Investigation and Association of American Physicians. She was recognized with the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School (HMS). 

Dr. Stegmaier received her undergraduate degree from Duke University where she graduated valedictorian, medical degree from HMS, and trained in Pediatrics and Pediatric Hematology/Oncology at BCH and DFCI. 

Photo by Sam Ogden.